Showing results (141-150 of 420) with videos related to
Sort By:
Pageof 42
Journal of Translational Medicine|April 17, 2013
Serum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratiosArduino A Mangoni, Angelo Zinellu, Ciriaco Carru, et al.Expert Opinion on Drug Metabolism & Toxicology|October 20, 2020
Alterations in drug disposition in older adults: a focus on geriatric syndromesDorsa Maher, Nagham Ailabouni, Arduino A Mangoni, et al.The Cochrane Database of Systematic Reviews|January 19, 2019
Methotrexate for psoriatic arthritisTom D Wilsdon, Samuel L Whittle, Tilenka Rj Thynne, et al.International Journal of Cancer|December 22, 2015
Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trialsMichael J Sorich, Ganessan Kichenadasse, Andrew Rowland, et al.Age and Ageing|April 6, 2013
Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?Matthew F G Greig, Stuart B Rochow, Michael A Crilly, et al.Clinical Interventions in Aging|September 24, 2014
Drug Burden Index in older adults: theoretical and practical issuesLisa Kouladjian, Danijela Gnjidic, Timothy F Chen, et al.Age and Ageing|February 3, 2023
New horizons in managing older cancer survivors: complexities and opportunitiesAnna R A Mislang, Arduino A Mangoni, Angela Molga, et al.Internal Medicine Journal|December 13, 2024
Characteristics of paracetamol poisoning in a local health network and consistency of hospital management with national guidelinesSimon P Hurley, Chris Horwood, Jake Mallon, et al.Clinical Medicine (London, England)|December 13, 2024
The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumoniaYogesh Sharma, Campbell Thompson, Angelo Zinellu, et al.British Journal of Cancer|May 27, 2016
Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial dataMichael J Sorich, Andrew Rowland, Ganessan Kichenadasse, et al.Pageof 42